Evaluation of live attenuated influenza vaccines in children 6-18 months of age: Safety, immunogenicity, and efficacy

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1313-1319

  Gruber, William C ^a   Belshe, Robert B ^f   King, James C ^f   Treanor, John J ^f   Piedra, P A ^f   Wright, Peter F ^f   Reed, George W ^f   Anderson, Edwin ^f   Newman, Fran ^f   Cannon, J ^b   Keane, V ^c   Hall, C B ^d   Sannella, E ^e   Thompson, J ^e   Tollefson, S ^e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN G; INFLUENZA VACCINE; LIVE VACCINE; PLACEBO;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEVER; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFANT; INFLUENZA VIRUS A; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SEROCONVERSION; SYMPTOMATOLOGY; VACCINATION; VIRUS STRAIN;

EID: 19244364740     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1313     Document Type: Article

References (25)

1. Frank AL, Taber LH, Wells JM. Comparison of infection rates and severity of illness for influenza A subtypes H1N1 and H3N2. J Infect Dis 1985;151:73-80.
2. Kim HW, Brandt CD, Arrobio JO, et al. Influenza A and B virus infection in infants and young children during the years 1957-1976. Am J Epidemiol 1979;109:464-79.
3. Arden NH, Cox NJ, Schonberger LB. Prevention and control of influenza. Part I. Vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1994;43(RR-9):1-13.
4. Belshe RB, Van Voris LP, Bartram J, et al. Live attenuated influenza A virus vaccines in children: results of a field trial. J Infect Dis 1984;150:834-40.
5. Feldman S, Wright PF, Webster RG, et al. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus. J Infect Dis 1985;152:1212-8.
6. Edwards KM, Dupont WD, Westrich MK, et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994;169:68-76.
7. Maassab HF. Adaptation and growth characteristics of influenza virus at 25°C. Nature 1967;213:612-4.
8. Maassab HF, Kendal AP, Abrams GD, Monto AS. Evaluation of a cold-recombinant influenza virus vaccine in ferrets. J Infect Dis 1982;146:780-90.
9. Cox NF, Maassab HF, Kendal AP. Comparative studies of wild-type and cold mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25° between recent H3N2 and H1N1 epidemic strain and cold-adapted A/Ann Arbor/6/60. Virology 1979;97:190-4.
10. Davenport FM, Hennessy AV, Maassab HF, et al. Pilot studies on recombinant cold-adapted live type A and B12 influenza virus vaccines. J Infect Dis 1977;136:17-25.
11. Herlocher ML, Maassab HF, Webster RG. Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus. Proc Natl Acad Sci 1993;90:6032-6.
12. Wright PF, Okabe N, McKee KTJ, et al. Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis 1982;146:71-9.
13. Wright PF, Karzon DT. Live attenuated influenza vaccines [review]. Prog Med Virol 1987;34:70-88.
14. Belshe RB, Swierkosz EM, Anderson EL, Newman FK, Nugent SL, Maassab HF. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine. J Infect Dis 1992;165:727-32.
15. Piedra PA, Glezen WP, Mbawuike I, et al. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children. Vaccine 1993;11:718-24.
16. Gruber WC, Kirschner K, Tollefson S, et al. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. J Infect Dis 1993;168:53-60.
17. Swierkosz EM, Newman FK, Andersen EL, et al. Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children. J Infect Dis 1994;169:1121-4.
18. Wright PF, Bhargava M, Johnson PR, Thompson J, Karzon DT. Simultaneous administration of live, attenuated influenza A vaccines representing different serotypes. Vaccine 1985;3:305-8.
19. Tolpin MD, Massicot JG, Mullinix MG, et al. Genetic factors associated with loss of the temperature-sensitive phenotype of the influenza A/Alaska/77-ts-1A2 recombinant during growth in vivo. Virology 1981;112:505-7.
20. Phelan MA, Mayner RE, Becker DJ, Ennis FA. Purification of influenza virus glycoproteins for the preparation and standardization of immunologic potency testing reagents. J Biol Stand 1980;8:233-42.
21. Murphy BR, Phelan MA, Nelson DL, et al. A hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol 1981;13:554-60.
22. Gruber WC, Campbell PW, Thompson JM, et al. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J Infect Dis 1994;169:241-7.
23. Gruber WC, Darden P, Still JG, Lohr J, Wright PF, NIHAVyeth-Ayerst ca Influenza Vaccine Investigators Group. Dose-response, safety, and immunogenicity of bivalent live attenuated cold-adapted (ca) influenza vaccine in healthy children 2-36 months old [abstract 1069]. Pediatr Res 1994;35:181A.
24. Romanova JR, Ermachenko TA, Alexandrova GI, et al. Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice. Vaccine 1994;12:23-7.
25. Clements ML, Makhene MK, Karron RA, et al. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. J Infect Dis 1996;173:44-51.